vaccine for the prevention of COVID-19 to include children ages 5 through 11 years of age. Summarizes key points for parents and caregivers about effectiveness and safety of the vaccine, ongoing safety monitoring systems in place to detect and investigate potential safety problems; and describes the studies/methodologies that supported the authorization decision.
Bacerra-Cardona Letter on COVID-19 Vaccination for Children (11-08-21): Encourages families, students, community members and educators to actively support the vaccination process for K-12 children. The U.S. Secretaries of Health and Human Services and of Education make three joint requests, and share information and resources to support them: 1. Host a COVID-19 vaccine clinic at your school(s); 2. distribute information about the COVID-19 vaccine to all families with children ages five through eleven years old; and 3. hold conversations with your school communities on the covid-19 vaccine.
Coverage is Available for COVID-19 Vaccinations for Eligible Children Ages 5 through 11: Reminds eligible consumers that coverage is available under Medicare, Medicaid, the Children’s Health Insurance Program (CHIP), and in the commercial market for COVID-19 vaccination without any out-of-pocket co-payment. CMS issues this reminder in conjunction with the CDC and FDA authorization of the Pfizer-BioNTech COVID-19 Vaccine for children in this age group. “The COVID-19 vaccine is the best way to keep children safe. The strongest protection against COVID-19, including the Delta variant, is to get vaccinated,” said CMS Administrator Chiquita Brooks-LaSure. “I encourage parents everywhere to talk with their pediatrician, school nurse, or other trusted healthcare provider about any questions they may have and to get their children vaccinated as soon as possible.” People can visit vaccines.gov (English) or vacunas.gov (Spanish) to search for nearby locations to receive a vaccine.
Safety of COVID-19 Vaccines: Explains the safety, efficacy and side effects of COVID-19 vaccines with official CDC guidance and information (updated 08/12/21).
Understanding the Federal Retail Pharmacy Program for COVID-19 Vaccination: Explains the Federal Retail Pharmacy Program, a collaboration between the federal government, states and territories, and 21 national pharmacy partners and independent pharmacy networks to increase access to COVID-19 vaccination across the United States. This program is one component of the Federal government’s strategy to expand access to vaccines for the American public.
COVID-19 Vaccine Toolkit for School Settings and Childcare Programs: Provides COVID-19 vaccine information, as well as official CDC materials including posters, flyers, letters to staff, social media mesages, newsletter articles, and stickers, for staff in schools and childcare programs.
COVID-19 Vaccines for Teachers, School Staff, and Childcare Workers: Informs staff of the latest, official CDC information about how to get vaccinated.
FDA Approves First COVID-19 Vaccine (Spanish language version): Reports formal approval (08/23/21) of the Pfizer-BioNTech COVID-19 vaccine for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be available under emergency use authorization (EUA), including for individuals 12 through 15 years of age; and for the administration of a third dose in certain immunocompromised individuals. The FDA, an agency within the U.S. Department of Health and Human Services [DHHS], protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use.
What FDA's Full Approval of Pfizer-BioNTech COVID-19 Vaccine Means: Explains the parameters and significance of the 8/23/21 full authorization of the Pfizer COVID-19 vaccine. The American Medical Association [AMA] report explains the Pfizer vaccine (will be marketed as Comirnaty) is fully approved for use in individuals ages 16 and older to prevent COVID-19 disease. A recent survey from the Kaiser Fam